Introducing Menopause Hormone Therapy
Menopause hormone therapy (MHT) is a new term for what used to be called hormone replacement therapy or HRT. If you’ve never heard about menopause hormone therapy, it’s worth remembering that the change of name
Spend $99, get free U.S. shipping*
Tariff now required on U.S. shipments. Learn more »
Tel: 1-866-456-3768 Fax: 1-866-544-8993

For visual reference only; actual product may vary
US Name:
Vabysmo
Alternative Names:
Vabysmo
Active Ingredients:
Faricimab
Brand Manufacturer:
Manufacturer Location:
Click here to view Product Insert
Click here to view Product Insert
Click here to view Product Insert

For visual reference only; actual product may vary
Vabysmo (faricimab) is a prescription intravitreal injection used to treat wet age-related macular degeneration (AMD) and diabetic macular edema (DME). It targets two key pathways that cause retinal fluid leakage, helping to reduce swelling and improve vision. This product requires cold shipping.
| Vabysmo Brand | 120mg/ml 1 Vial |
-
|
Our price: $1,672.00 |
Vabysmo is a prescription medication used to treat serious eye conditions in adults. It is specifically approved for neovascular (wet) age-related macular degeneration, also known as wet AMD. It also treats an eye condition called diabetic macular edema, or DME. Both conditions can cause fluid to build up in the macula. The macula is the part of your retina responsible for sharp, central vision. This fluid leakage leads to swelling that can cause blurry vision and permanent vision loss if left untreated. Vabysmo helps to manage these conditions to protect your sight.
Vabysmo works by blocking the activity of two proteins in the body. These proteins are called vascular endothelial growth factor-A (VEGF-A) and angiopoietin-2 (Ang-2). Both are major causes of fluid leakage from blood vessels in the retina. By targeting both pathways, Vabysmo provides a powerful, dual-action effect. It helps to reduce swelling in the macula and stabilize the blood vessels. This unique mechanism can lead to lasting control of the disease. It may also extend the time needed between treatments for many patients.
Vabysmo is for adults who have been diagnosed with wet AMD or diabetic macular edema. Your eye doctor (ophthalmologist) can determine if it is right for you. It can be used for patients who are new to treatment for these conditions. It is also an option for patients who are switching from another anti-VEGF medication. If you are experiencing blurry central vision or straight lines appearing wavy, you should see an eye doctor. A complete eye exam is needed to confirm a diagnosis before starting treatment.
Vabysmo is given by your ophthalmologist as an injection into the eye. This procedure is called an intravitreal injection. The area is numbed completely so you feel little to no pain. For wet AMD and DME, treatment often begins with one injection every four weeks for the first few months. After that, your doctor will check your vision and eye health. Based on your progress, the time between injections may be extended. Many patients can go as long as four months between doses. Your doctor will create a personalized dosing schedule for you.
Vabysmo can cause side effects, many of which are related to the injection itself. The most common side effect is a small bleed on the surface of the eye (conjunctival hemorrhage). Other common effects include eye floaters, eye pain, redness, and a temporary increase in eye pressure. Serious side effects are rare but can occur. These include a severe eye infection (endophthalmitis), retinal detachment, and cataracts. You should contact your doctor immediately if you experience severe eye pain, vision changes, or increased light sensitivity after treatment.
IsraelPharm offers a safe, convenient, and affordable way to get your Vabysmo prescription. We source all our medications from reputable manufacturers and licensed distributors. Our streamlined online ordering process is simple and secure. This saves you time and trips to a local pharmacy. We are committed to providing competitive prices on brand-name medications like Vabysmo. Our knowledgeable customer care team can assist you with any questions. We also ensure that temperature-sensitive products like Vabysmo are shipped in cold packaging to maintain their quality and effectiveness upon arrival.
Vabysmo is administered as an injection into the vitreous of the eye. This procedure, called an intravitreal injection, is performed by a qualified ophthalmologist in a clinical setting. The eye is numbed beforehand to minimize discomfort. The process is quick, but you will need someone to drive you home after the appointment as your vision will be blurry.
Vabysmo allows for a flexible dosing schedule that your doctor will personalize for you. Many patients start with a series of monthly injections. Based on your eye's response and vision stability, the time between treatments may be extended up to every four months. This can mean fewer clinic visits over time compared to other available treatments for this condition.
Vabysmo is the first and only bispecific antibody approved for the eye. It uniquely targets two different pathways, Angiopoietin-2 (Ang-2) and Vascular Endothelial Growth Factor-A (VEGF-A), that contribute to vision loss. This dual action helps stabilize blood vessels in the retina, potentially offering more durable results and longer-lasting effects than single-pathway inhibitors do.
Vabysmo can help improve and maintain vision for patients with wet AMD and DME. By reducing the swelling and fluid leakage in the macula, it helps the retina function better. While results vary between individuals, clinical studies have shown that many patients experience significant vision gains. The primary goal is to prevent further vision loss and often to recover some lost sight.
The most common side effect of Vabysmo is subconjunctival hemorrhage. This is a broken blood vessel on the white of the eye that looks like a red spot. Other common effects include eye pain, floaters, and a feeling of pressure in the eye after the injection. These symptoms are typically temporary and resolve without treatment within a few days.
Vabysmo carries a risk of serious side effects, although they are rare. These can include a serious infection inside the eye called endophthalmitis, retinal detachment, or a significant increase in eye pressure. You should immediately contact your doctor if you experience severe eye pain, significant changes in vision, or increasing redness or light sensitivity following your injection.
You should not drive yourself home after receiving a Vabysmo injection. Your eye will be dilated for the procedure, which can cause blurry vision and sensitivity to light. It is essential to arrange for someone else to drive you home from your appointment to ensure your safety. Your vision should typically return to normal within several hours.
Vabysmo can cause some temporary eye discomfort, or a gritty or scratching sensation. Your doctor may suggest using artificial tear eye drops to help soothe the eye. You should avoid rubbing your eye after the injection. If you experience severe or worsening pain, contact your doctor right away as it could indicate a more serious complication.
Vabysmo is administered locally into the eye, so it is not expected to interact with oral or systemic medications. However, it is very important to inform your doctor about all medications you take, including prescription drugs, over-the-counter medicines, and other eye drops. This allows your doctor to manage your treatment safely and effectively.
Missing a scheduled Vabysmo injection could allow the disease process to become active again. This can lead to new fluid buildup in the retina and a decline in vision. It is very important to adhere to the treatment schedule your doctor provides. If you must miss an appointment, contact your doctor’s office immediately to reschedule it.
Vabysmo is not a cure for wet AMD or diabetic macular edema, but it is a highly effective long-term treatment. It helps manage the chronic nature of these diseases by controlling fluid leakage and swelling in the retina. Consistent treatment according to your doctor's plan is the key to preserving your vision for as long as possible.
Vabysmo must be stored in a refrigerator between 2°C to 8°C (36°F to 46°F) and requires cold shipping. It should be kept in its original carton to protect it from light. Do not freeze the medication. This product will be shipped in validated temperature-controlled packaging to ensure it arrives safely and is ready for your doctor's office.
Vabysmo should not be used by individuals with an active infection in or around their eye. It is also not suitable for patients with a known allergy to faricimab or any of the other ingredients in the medication. Patients with active intraocular inflammation should not receive Vabysmo. Your doctor will conduct an exam to ensure it is appropriate for you.
You can generally use other prescribed or over-the-counter lubricating eye drops while receiving Vabysmo treatment. However, you should always discuss this with your doctor first. On the day of your injection, your doctor will give you specific instructions about using other drops before or after the procedure to prevent infection and manage your comfort safely.
Send Your Prescription
No Hidden Fees
Generally 7-10 Business Days

IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.
Menopause hormone therapy (MHT) is a new term for what used to be called hormone replacement therapy or HRT. If you’ve never heard about menopause hormone therapy, it’s worth remembering that the change of name

You’ve probably seen headlines questioning the safety of GLP-1 medicines – the cornerstone of the wave of the latest drugs that have revolutionized many areas of healthcare, primarily in control of type 2 diabetes and

People whose weight is higher than what is considered healthy for their height are described as having excessive body mass, clinically defined as being overweight or obese. Both of these can increase a person’s risk


